Hillhurst Biopharmaceuticals Receives Study May Proceed Letter From US FDA to Initiate Phase 1 Clinical Trial of HBI-002
SAN DIEGO, CA (April 23, 2021) Hillhurst Biopharmaceuticals, Inc. ...
About hillhurstbio
This author has not yet filled in any details.So far hillhurstbio has created 1 blog entries.